Min Cheng

1.6k total citations
57 papers, 1.1k citations indexed

About

Min Cheng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Min Cheng has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 17 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Min Cheng's work include Angiogenesis and VEGF in Cancer (11 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). Min Cheng is often cited by papers focused on Angiogenesis and VEGF in Cancer (11 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). Min Cheng collaborates with scholars based in China, United States and Singapore. Min Cheng's co-authors include Donghua Xu, Jing‐Hua Wang, Xiaodong Cui, Xiaoyun Zhang, Jinghan Yang, Xiumei Guan, Chengwen Jin, Shushan Yan, Hong Li and Shushan Yan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Min Cheng

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Cheng China 19 673 423 137 87 84 57 1.1k
Eva Hamade Lebanon 19 532 0.8× 331 0.8× 159 1.2× 77 0.9× 118 1.4× 50 1.2k
Jiayi Yao China 21 618 0.9× 346 0.8× 102 0.7× 55 0.6× 73 0.9× 58 1.1k
Hongyan Liang China 20 749 1.1× 324 0.8× 140 1.0× 105 1.2× 38 0.5× 49 1.3k
Yaguang Weng China 25 924 1.4× 549 1.3× 166 1.2× 103 1.2× 81 1.0× 53 1.4k
Rui Bai China 18 596 0.9× 321 0.8× 74 0.5× 94 1.1× 44 0.5× 78 994
Yu Hou China 20 680 1.0× 287 0.7× 103 0.8× 48 0.6× 68 0.8× 55 1.0k
Leilei Zhang China 19 858 1.3× 481 1.1× 177 1.3× 97 1.1× 29 0.3× 48 1.4k

Countries citing papers authored by Min Cheng

Since Specialization
Citations

This map shows the geographic impact of Min Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Cheng more than expected).

Fields of papers citing papers by Min Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Cheng. The network helps show where Min Cheng may publish in the future.

Co-authorship network of co-authors of Min Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Min Cheng. A scholar is included among the top collaborators of Min Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Cheng. Min Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oh, Daniel, Min Cheng, Shujing Liu, et al.. (2025). Enhancing Chimeric Antigen Receptor T‐Cell Generation via Microfluidic Mechanoporation and Lipid Nanoparticles. Small. 21(17). e2410975–e2410975. 5 indexed citations
2.
Li, Hong, et al.. (2025). Natural medicines target tumor vascular microenvironment to inhibit tumor. Genes & Diseases. 12(6). 101623–101623. 1 indexed citations
3.
Hua, Yulin, et al.. (2024). Reactive oxygen species sensitive nanomicelles promote the antifungal activity of ketoconazole against Candida albicans in vulvovaginal candidiasis. Colloids and Surfaces B Biointerfaces. 243. 114140–114140. 1 indexed citations
4.
Li, Lanlan, et al.. (2024). Traditional Chinese Medicine-based Treatment in Cardiovascular Disease: Potential Mechanisms of Action. Current Pharmaceutical Biotechnology. 25(17). 2186–2199. 5 indexed citations
5.
Liang, Jing, Haiyan Chu, Ran Yan, et al.. (2024). Linc-ROR Modulates the Endothelial-Mesenchymal Transition of Endothelial Progenitor Cells through the miR-145/Smad3 Signaling Pathway. Physiological Research. 73(4). 565–576. 1 indexed citations
6.
Cui, Xiaodong, et al.. (2023). Micropeptides: origins, identification, and potential role in metabolism-related diseases. Journal of Zhejiang University SCIENCE B. 24(12). 1106–1122. 4 indexed citations
8.
Tang, Hong-Wen, Jui–Hsia Weng, Yanhui Hu, et al.. (2021). mTORC1-chaperonin CCT signaling regulates m 6 A RNA methylation to suppress autophagy. Proceedings of the National Academy of Sciences. 118(10). 53 indexed citations
9.
Zhang, Xiaoyun, et al.. (2021). Advances in the Occurrence of Pyroptosis: A Novel Role in Atherosclerosis. Current Pharmaceutical Biotechnology. 22(12). 1548–1558. 10 indexed citations
10.
Fu, Jie, et al.. (2021). The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis. Frontiers in Genetics. 12. 733871–733871. 23 indexed citations
11.
Yang, Xiaoxu, Guohui Wang, Xiaolei Huang, Min Cheng, & Yangyang Han. (2020). RNA-seq reveals the diverse effects of substrate stiffness on epidermal ovarian cancer cells. Aging. 12(20). 20493–20511. 6 indexed citations
12.
Li, Jifeng, Yanting He, Meiyue Wang, et al.. (2020). Oscillating shear stress mediates mesenchymal transdifferentiation of EPCs by the Kir2.1 channel. Heart and Vessels. 35(10). 1473–1482. 7 indexed citations
13.
Yang, Jinghan, et al.. (2020). CircRNA_09505 aggravates inflammation and joint damage in collagen-induced arthritis mice via miR-6089/AKT1/NF-κB axis. Cell Death and Disease. 11(10). 833–833. 131 indexed citations
14.
Huang, Xiaolei, et al.. (2020). Biophysical signal transduction in cancer cells: Understanding its role in cancer pathogenesis and treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(2). 188402–188402. 5 indexed citations
15.
Yang, Jinghan, et al.. (2020). Mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles: Potential roles in rheumatic diseases. World Journal of Stem Cells. 12(7). 688–705. 20 indexed citations
16.
Yan, Shushan, Pingping Wang, Jing‐Hua Wang, et al.. (2019). Long Non-coding RNA HIX003209 Promotes Inflammation by Sponging miR-6089 via TLR4/NF-κB Signaling Pathway in Rheumatoid Arthritis. Frontiers in Immunology. 10. 2218–2218. 88 indexed citations
17.
Wang, Xia, et al.. (2018). Fucoxanthin Exerts Cytoprotective Effects against Hydrogen Peroxide-induced Oxidative Damage in L02 Cells. BioMed Research International. 2018. 1–11. 41 indexed citations
18.
Cheng, Min, et al.. (2018). Clinical value of myocardial enzymes and umbilical artery blood gas analysis in diagnosis and treatment of neonatal asphyxia. Zhongguo jiceng yiyao. 25(7). 847–850. 1 indexed citations
19.
Cheng, Min, et al.. (2013). Biological properties of bone marrow-derived early and late endothelial progenitor cells in different culture media. Molecular Medicine Reports. 8(6). 1722–1728. 18 indexed citations
20.
Cheng, Min, Xin Li, Xiaodong Cui, et al.. (2013). Puerarin Accelerates Re-Endothelialization in a Carotid Arterial Injury Model. Journal of Cardiovascular Pharmacology. 62(4). 361–368. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026